By using a diverse set of transcriptomic SARS-CoV-2 signatures, US researchers put to use their previously developed drug repositioning pipeline to pinpoint potential drug candidates for the treatment of coronavirus disease (COVID-19). The study is currently available on the bioRxiv* preprint server.
Impaired blood clot contraction predicts imminent postoperative thrombosis
Cleveland Clinic-led study identifies features associated with pathogenic and benign variants
UVA research sheds light on how cancer remodels our chromosomes
Antibiotic use patterns and patient transfers in hospitals may drive the emergence of drug resistance
Black Hispanic individuals have worse COVID-19 outcomes
Dietary 1H-NMR “Fingerprints” Could Help Fight Against Chronic Disease
The Anatomy of the Human Brain
An Overview of Blood Types
Insight into the Spinal Cord
Characterization of Pancreatic Cancer Cells Response to Peptigels that Mimic Healthy and Tumor Tissue Properties
Sensitive and Accurate Diagnostic Tests of COVID-19 with High-Quality SARS-CoV-2 Proteins
OHAUS Supports the Fight Against Covid-19
Identifying Illegal Food Products Using Chromatography
Recent Developments in Chromatography
What is Flash Column Chromatography?
AI research using hastily gathered data for COVID-19 is a dangerous trend does not help patients or physicians and damages the AI community's reputation.
Mediastinal infections are primarily related to surgery, perforation of the esophagus and infectious spread from adjacent regions.
The process of organogenesis is the formation of organs during embryonic development. This article looks at the various organs formed.
Yinan Jiang, Product Development Manager at ACROBiosystems
In this interview, Dr. Yinang Jiang discusses ACROBiosystems and their efforts in the fight against COVID-19 and the search for a vaccine
David Apiyo, Senior Manager, Applications, at Sartorius AG
In this interview, News-Medical talks to David Apiyo, a senior manager of applications at Sartorius AG, about monoclonal antibody development and characterization.
In this interview, Rebekah Stibbs from EKF Diagnostics talks to News-Medical about eliminating the cold chain with COVID-19 molecular transport media.
Building a Successful Email Campaign for a Scientific Audience
Using Webinars to Tell Science Stories – PART II
Reaching Scientists Through Newsletters